| [1] | Kubinyi, H,“Similarity and dissimilarity: A medicinal chemist’s view”,Perspectives in Drug Discovery and Design, 9, 225-252, Jan. 1998. |
| |
| [2] | Flower, D.R,“On the properties of bit string-based measures of chemical similarity”, Journal of Chemical Informationand Computer Science, 38, 379-386, May 1998. |
| |
| [3] | Holliday, J.D., Hu, C-Y., Willett, P,“Grouping of coefficients for the calculation of intermolecular similarity and dissimilarity using 2D fragment bit-strings”,Combinatorial Chemistry and High-Throughput Screening, 5, 155-166, Mar. 2002. |
| |
| [4] | Mestres, J., Rohrer, D.C., Maggiora, G.M, “A molecular-field-based similarity study of non-nucleoside HIV-1 reverse transcriptase inhibitors. 2. The relationship between alignment solutions obtained from conformationally rigid and flexible matching”, Journal of Computer Aided Molecular Design, 14, 39-51, Jan. 2000. |
| |
| [5] | Mestres, J., Rohrer, D.C., Maggiora, G.M, “A molecular field based similarity study of non-nucleoside HIV-1 reverse transcriptase inhibitors”,Journal of Computer Aided Molecular Design, 13, 79-93, Jan. 1999. |
| |
| [6] | Thorner, D.A., Wild, D.J., Willett, P., Wright, P.M, “Similarity searching in files of three-dimensional chemical structures: Flexible field-based searching of molecular electrostatic potentials”,Journal of Chemical Information and Computer Science, 36, 900-908, Jul.1996. |
| |
| [7] | Geneste, H., Backfisch, G., Braje, W., Delzer, J., Haupt, A., Hutchins, C.W,“Synthesis and SAR of highly potent and selective dopamine D3-receptor antagonists: Quinolin(di)one and benzazepin(di)one derivatives”,Bioorganic and Medicinal Chemistry Letters, 16, 658-662, Feb. 2006. |
| |
| [8] | Masaguer, F.C., Ravina, E., Fontenla, J.A., Brea, J., Tristan, J., Loza, M.I,“Butyrophenone analogues in the carbazole series as potential atypical antipsychotics: Synthesis and determination of affinities at D2, 5-HT2A, 5-HT2B and 5-HT2C receptors”,EuropeanJournal of Medicinal Chemistry, 35, 83-95, Jan. 2000. |
| |
| [9] | Reitz, A.B., Bennett, D.J., Blum, P.S., Codd, E.E., Maryanoff, C.A., Ortegon, M.E,“A new arylpiperazine antipsychotic with high D2/D3/5-HT1a/α1 adrenergic affinity and a low potential for extrapyramidal effects”,Journal of Medicinal Chemistry, 37, 1060-1062, Apr. 1994. |
| |
| [10] | Cole, D.C., Ellingboe, J.W., Lennox, W.J., Mazandarani, H., Smith, D.L., Stock, J.R,“N1-arylsulfonyl-3-(1, 2, 3, 6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists”,Bioorganic and Medicinal Chemistry Letters, 15, 379-383, Jan. 2005. |
| |
| [11] | Xu, R., Lever, J.R., Lever, S.Z, “Synthesis and in vitro evaluation of tetrahydroisoquinolinylbenzamides as ligands for σ receptors”, Bioorganic and Medicinal Chemistry Letters, 17, 2594-2597, May 2007. |
| |
| [12] | Zhao, H., Thurkauf, A., He, X., Hodgetts, K., Zhang, X., Rachwal, S, “Indoline and piperazinecontaining derivatives as a novel class of mixed D2/D4 receptor antagonists. Part 1: Identification and structure–activity relationships”, Bioorganic and Medicinal Chemistry Letters, 12, 3105-3109, Nov. 2002. |
| |
| [13] | Bali, A., Sharma, K., Bhalla, A., Bala, S., Reddy, D., Singh, A,“Synthesis, evaluation and computational studies on a series of acetophenone based 1-(aryloxypropyl)-4-(chloroaryl) piperazines as potential atypical antipsychotics”,European Journal of Medicinal Chemistry, 45, 2656-2662, Jun. 2010. |
| |